New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide ... MarketWatch (press release) The study title is "An Open Label Non-Randomized Pilot Study To Evaluate the Safety of the GeNO NITROSYL Delivery System in Patients Being Evaluated for Heart Transplantation." This is the first human data to be presented with the Company's novel NO ... |
